Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
This dual engagement provides an effective approach for managing blood sugar and weight
Why Muscle Matters in GLP-1 Programs Muscle is a metabolically active tissue
According to information presented at a GIC board meeting Thursday, in August 2022, the GIC had 798 non-Medicare members using GLP-1 drugs for weight loss and 2,559 for diabetes, costing GIC $4.2 million
Absolute Contraindications Active malignancy Pregnancy and lactation Severe hypoglycemia disorders Known hypersensitivity to IGF-1 Active proliferative retinopathy Relative Contraindications Diabetes mellitus Renal impairment Cardiac impairment History of hyperplasia Family history of certain cancers Severe hepatic impairment Dosing & Administration Starting Dose 2050 mcg/day subcutaneously Begin at the lower end for sensitive patients Assess tolerance for 12 weeks before titration Therapeutic Range 50120 mcg/day for most indications Maximum dose: 200 mcg/day Individualize dosing based on response and tolerance Cycling Protocol 46 weeks on therapy 4 weeks off therapy Helps prevent receptor desensitization Supports long-term efficacy Administration Guidelines Hypoglycemia Prevention: Always administer IGF-1 LR3 with or shortly after carbohydrate-containing meals
Its potency depends on the compounding pharmacy
US$ 28.94
US$ 20.71
US$ 27.93
US$ 27.24
US$ 29.50
